183 related articles for article (PubMed ID: 36216758)
21. Total neoadjuvant therapy
Tuta M; Boc N; Brecelj E; Peternel M; Velenik V
World J Gastrointest Oncol; 2021 Feb; 13(2):119-130. PubMed ID: 33643528
[TBL] [Abstract][Full Text] [Related]
22. Pathologic Outcomes of Short-Course and Long-Course Radiotherapy for Locally Advanced Rectal Cancers Treated With Total Neoadjuvant Therapy.
Williams B; Gupta A; Iype P; Woll S; Koller SE; Shin J; Cologne KG; Lee SW; Duldulao MP
Am Surg; 2024 May; ():31348241256055. PubMed ID: 38770756
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
24. How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada.
Crawford A; Firtell J; Caycedo-Marulanda A
J Gastrointest Cancer; 2019 Jun; 50(2):260-268. PubMed ID: 29388060
[TBL] [Abstract][Full Text] [Related]
25. Short-course radiotherapy for rectal cancer: real-world evidence in Argentina.
Tissera NS; Freile B; Waisberg F; Esteso F; Galli M; Loria FS; Luca R; Pedraza II; Enrico DH; Chacón C; Huertas E; Chacón MR; O'Connor JM
Ecancermedicalscience; 2023; 17():1555. PubMed ID: 37396101
[TBL] [Abstract][Full Text] [Related]
26. Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
Shamseddine A; Zeidan YH; Kreidieh M; Khalifeh I; Turfa R; Kattan J; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Khoury C; El Husseini Z; Charafeddine M; Al Darazi M; Geara F
BMC Cancer; 2020 Sep; 20(1):831. PubMed ID: 32873251
[TBL] [Abstract][Full Text] [Related]
27. Patterns of Care for Patients With Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy at Predominately Academic Centers between 2016-2020: An NCDB Analysis.
Liu J; Ladbury C; Glaser S; Fakih M; Kaiser AM; Chen YJ; Williams TM; Amini A
Clin Colorectal Cancer; 2023 Jun; 22(2):167-174. PubMed ID: 36878806
[TBL] [Abstract][Full Text] [Related]
28. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Cercek A; Roxburgh CSD; Strombom P; Smith JJ; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Seier K; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Crane CH; Gollub MJ; Garcia-Aguilar J; Saltz LB; Weiser MR
JAMA Oncol; 2018 Jun; 4(6):e180071. PubMed ID: 29566109
[TBL] [Abstract][Full Text] [Related]
29. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
[No Abstract] [Full Text] [Related]
30. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
[TBL] [Abstract][Full Text] [Related]
31. Organ preservation following short-course radiotherapy for rectal cancer.
Nilsson PJ; Ahlberg M; Kordnejad S; Holm T; Martling A
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34686879
[TBL] [Abstract][Full Text] [Related]
32. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
[TBL] [Abstract][Full Text] [Related]
33. Total neoadjuvant therapy in patients with locally advanced rectal cancer: A tertiary medical center experience.
Husseini ZE; Haibe Y; Bouferraa Y; Kreidieh M; Darazi MA; Mukherji D; Temraz S; Charafeddine M; Shamseddine A
Mol Clin Oncol; 2021 Oct; 15(4):220. PubMed ID: 34476104
[TBL] [Abstract][Full Text] [Related]
34. Comparison of pathological response of standard chemoradiotherapy versus short course radiotherapy in rectal carcinoma: A pilot study.
Nagarjun BR; Shah A; Gami A; Gandhi J; Parikh A; Modi V
Indian J Pathol Microbiol; 2023; 66(4):708-713. PubMed ID: 38084520
[TBL] [Abstract][Full Text] [Related]
35. Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort study.
Couwenberg AM; Burbach JPM; Intven MPW; Consten ECJ; Schiphorst AHW; Smits AB; Wijffels NAT; Heikens JT; Koopman M; van Grevenstein WMU; Verkooijen HM
Acta Oncol; 2019 Apr; 58(4):407-416. PubMed ID: 30656996
[TBL] [Abstract][Full Text] [Related]
36. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
[TBL] [Abstract][Full Text] [Related]
37. Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
Voogt ELK; Schaap DP; van den Berg K; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Willems J; Cnossen JS; Peulen HMU; Nederend J; van Lijnschoten G; Burger JWA; Rutten HJT
Eur J Surg Oncol; 2021 Sep; 47(9):2429-2435. PubMed ID: 34030921
[TBL] [Abstract][Full Text] [Related]
38. The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer.
Bhudia J; Glynne-Jones R
Curr Treat Options Oncol; 2022 Apr; 23(4):453-473. PubMed ID: 35312962
[TBL] [Abstract][Full Text] [Related]
39. Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review.
Mori R; Uemura M; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Mizushima T; Doki Y; Eguchi H
World J Surg Oncol; 2022 May; 20(1):166. PubMed ID: 35619103
[TBL] [Abstract][Full Text] [Related]
40. Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.
Giunta EF; Bregni G; Pretta A; Deleporte A; Liberale G; Bali AM; Moretti L; Troiani T; Ciardiello F; Hendlisz A; Sclafani F
Cancer Treat Rev; 2021 May; 96():102177. PubMed ID: 33798955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
